The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.

The present invention relates to improved assisted reproductive technology using highly purified menotropin (HP-hMG) to stimulate follicle development in controlled ovarian stimulation, particularly in women at risk of a high ovarian response to controlled ovarian stimulation.

An instrument for fixedly transplanting a living body embryo into a uterus has an instrument, for transplanting the living body embryo into the uterus, which is to be inserted into a uterus and a magnetic embryo accommodation container holding instrument (transferred embryo fixing instrument) to be attached to the living body. The instrument for transplanting the living body embryo into the uterus has an embryo accommodation container having an embryo accommodation part having an embryo insertion portion communicating with outside and a magnetic material and a shaft-shaped container transfer tool for separably holding the embryo accommodation container at its distal end portion. The magnetic container holding instrument has an attaching part to be attached to an epidermis of the living body and a magnet capable of attracting the magnetic material of the embryo accommodation container thereto.

A single, handheld medical device for performing an endometrial abrasion and/or HSG procedure is disclosed. The preferred embodiment comprises a body that includes a handle integrally connected to an arm with an articulating member at its distal end. The handle comprises a means for storing and pumping a fluid into the uterus so that ultrasound or x-ray can be used to determine the location of the articulating member within the uterus. The arm further comprises a shielding device that is operable to slidably engage the arm of the device and the shield and the arm are configured to cover and sealingly engage the external os of the cervix to prevent reflux during use. Optional viewing means are disclosed, including an imaging screen mountably attached to the device and in communication with a scope disposed within the arm.

Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may also be useful in the treatment of infertility associated with PCOS.

The invention provides novel non-invasive in vitro methods for assessing the metabolic condition of oocytes and/or embryos with fluorescence lifetime imaging microscope, that can be used, for example, in assessment of oocytes and embryos in assisted reproductive technologies.

The invention relates to an oocyte-holding pipette for sperm injection methods without cytoplasmic aspiration, comprising an elongate, narrow, hollow, cylindrical body, inside which runs a suction conduit that communicates with a working end in order to hold an oocyte, said working end being flared to form a funnel defining an internal conical cavity, the proximal end of which, of smaller diameter, communicates with the suction conduit and the distal end of which, of larger diameter, is dimensioned to receive the oocyte in a tight-fitting manner, such that, upon aspirating same via the suction conduit, the oocyte remains partially trapped inside and becomes deformed, changing from its spherical shape in the resting state to an oval shape that tensions the surface and increases the turgor.

Described here are methods and systems for the manipulation of ovarian tissues. The methods and systems may be used in the treatment of polycystic ovary syndrome (PCOS). The systems and methods may also be useful in the treatment of infertility associated with PCOS.

Method for producing mobility in immobile cells in in vivo or in vitro fertilization. The method includes producing mobility in individual immobile cells that are connected to a microstructure. The microstructure is composed at least partially of magnetic materials and a non-reciprocal movement of the microstructure with the immobile cell is executed by a time-varying, three-dimensional external magnetic field.

Method for producing mobility in immobile cells in in vivo or in vitro fertilization. The method includes producing mobility in individual immobile cells that are connected to a microstructure. The microstructure is composed at least partially of magnetic materials and a non-reciprocal movement of the microstructure with the immobile cell is executed by a time-varying, three-dimensional external magnetic field.